NIGERIA- mPharma, a leading patient-centered technology-driven healthcare company has launched mutti+ to continue its ambitious plan to provide as many Nigerians as possible access to critical healthcare.
Commenting about mutti+ during its launch, the company’s Chief Executive Officer and Co-founder Gregory Rockson of mutti+, “We believe that the mutti+ program will help to drive better health outcomes for patients and support the goals of World Health Day to build a fairer, healthier world for everyone.”
The program is set to reach over 200,000 Nigerians within its first year of launch and aims at providing non-urgent primary care to subscribers to mutti pharmacy.
Included in this new inclusive package are free primary care consultation, free laboratory tests, and 150 medications for less than US$10.
Considering the prohibitive nature of comprehensive care in Nigeria, attributed to the fact that more than 20 million Nigerians earn less than a dollar a day, this continued investment proposition by mPharma will be a welcome relief.
An analysis conducted by mPhrama of over 500,000 patient visits to mutti pharmacies in 2022, identified 14 common diseases 90% of them sought treatment for.
The ailments include Malaria, Diarrhoea/Gastroenteritis, Peptic Ulcer, Pneumonia, Diabetes, and Hypertension.
mPharma has built a treatment plan and using the WHO essential drug list to seek the best viable generic drugs and point-of-care testing (PoCT) they created a subscription plan that costs less than US$5 a month.
There are more than 100 million internet users in Nigeria alone. Therefore, if healthcare companies can tap into this huge pool of people, they could increase access to and availability of essential services to their patients.
Studies conducted by smart analytics show that the COVID global health phenomenon resulted in a 6-year digital transformation acceleration, with 97% of business executives stating that the pandemic expedited their digitalization efforts.
“To leverage on the ability to reach customers on time and in a more dynamic way, health care provides must rethink their business model and mPharma will be at the heart of this revolution,” was the resounding statement made by Gregory Rockson.
Only two years ago, the platform acquired a majority stake in Nigeria’s pharmaceutical group, Healthplus with its partner AltaSemper.
This shows its deliberate intention to continue to grow and lay the important groundwork to becoming a major player in the space.
For all the latest healthcare industry news from Africa and the World, subscribe to our NEWSLETTER, and YouTube Channel, follow us on Twitter and LinkedIn, and like us on Facebook.
